Anticancer agent 46
Anticancer agent 46 (compound 2) is a potent anticancer agent. Anticancer agent 46 shows antiproliferative activity with an IC50 of 0.986 µM for MGC803 cells. Anticancer agent 46 has the potential for the research of gastric cancer[1].
Product Specifications
CAS Number
[2426686-17-9]
UNSPSC
12352005
Hazard Statement
H301
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-46.html
Purity
95.73
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
C/C(C1=CC(Cl)=CC=C1O)=N\NC(NC2=CC=CC=C2)=S
Molecular Formula
C15H14ClN3OS
Molecular Weight
319.81
Precautions
P264-P270-P330-P405-P501
References & Citations
[1]Zhang XH, et al. Thiosemicarbazone-based lead optimization to discover high-efficiency and low-toxicity anti-gastric cancer agents. Eur J Med Chem. 2020 Aug 1;199:112349.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15339976 1 Vial
Lentiviral human HMX2 shRNA (UAS) - Lentiviral human HMX2 shRNA (UAS, RFP) plasmid
Ask
View Details 
218870-01 20 µL
CHAF1B (CAF1, MPP7, CAF-1, CAF1A, CAF1P60, CAF-IP60, MPHOSPH7, Chromatin Assembly Factor 1 Subunit B) discontinued
Ask
View Details 218870-02 100 µL
CHAF1B (CAF1, MPP7, CAF-1, CAF1A, CAF1P60, CAF-IP60, MPHOSPH7, Chromatin Assembly Factor 1 Subunit B) discontinued
Ask
View Details 
MBS1357522-01 0.5 mg (E-Coli)
Recombinant Rickettsia conorii Uncharacterized protein RC1356 (RC1356), partial
Ask
View Details